Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Former FBI Director Robert Mueller has Parkinson’s disease: report

by admin September 1, 2025
September 1, 2025
Former FBI Director Robert Mueller has Parkinson’s disease: report

Former FBI Director Robert Mueller was diagnosed with Parkinson’s disease, his family revealed to the New York Times.

Mueller is the former special counsel who led the Russia investigation into President Donald Trump’s 2016 campaign.

Mueller, 81, was diagnosed in 2021 and retired from public life the following year after briefly teaching law, according to a family statement provided to The Times.

‘Bob was diagnosed with Parkinson’s disease in the summer of 2021. He retired from the practice of law at the end of that year. He taught at his law school alma mater during the fall of both 2021 and 2022, and he retired at the end of 2022,’ the statement said.

This post appeared first on FOX NEWS

previous post
Earthwise Advertising & Investor Awareness Campaign
next post
Trump says he will require voter ID with executive order

Related Posts

Tax cuts, work requirements and asylum fees: Here’s...

July 2, 2025

Schumer says ‘oligarchs’ keep him up at night,...

March 19, 2025

Trump-district Democrat warns party ‘in trouble’ ahead of...

March 25, 2025

Maduro trapped with few retaliation options after Trump...

December 14, 2025

USAID instructions for fired employees gives them 15...

February 26, 2025

Trump says US will deal ‘directly’ with Iran...

April 8, 2025

Russian leader claims multiple countries prepped to provide...

June 23, 2025

Several provisions fail to pass muster with Senate...

June 21, 2025

Trump admin secures pledge from 75% of health...

June 24, 2025

Trump’s ‘two sexes’ executive order comes on heels...

January 26, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved